Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.47 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | HPGD | P15428 | 5/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 7/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.41 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5845182 | 0.78 | PDE10A (0.47) | MAPTMEN1KMT2APDE10AALDH1A1 | |
| SCHEMBL6352308 | 0.78 | PDE10A (0.47) | MAPTMEN1KMT2APDE10AALDH1A1 | |
| SCHEMBL6008088 | 0.78 | PDE10A (0.47) | MAPTMEN1KMT2APDE10AALDH1A1 | |
| SCHEMBL95119 | 0.78 | ALDH1A1 (0.47) | MAPTMEN1KMT2APDE10AALDH1A1 | |
| SCHEMBL31526085 | 0.78 | PDE10A (0.47) | MAPTMEN1KMT2APDE10AALDH1A1 | |
| SCHEMBL2747071 | 0.78 | PDE10A (0.47) | MAPTMEN1KMT2APDE10AALDH1A1 | |
| SCHEMBL1997041 | 0.75 | ALDH1A1 (0.45) | MAPTMEN1KMT2ACHEK1ALDH1A1 | |
| SCHEMBL31184333 | 0.75 | NQO2 (0.46) | MAPTMEN1KMT2ACHEK1ALDH1A1 | |
| SCHEMBL20951862 | 0.75 | HRH4 (0.44) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL15689092 | 0.75 | PTGES (0.39) | CHEK1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116217500-B | Cyano quinoxaline red light thermal excitation delayed fluorescent material, synthetic method and application thereof | 黑龙江大学 | 2025-05-16 | — | — | CN | claimed |
| CN-116217500-A | Cyano quinoxaline red light thermal excitation delayed fluorescent material, synthetic method and application thereof | 黑龙江大学 | 2023-06-06 | — | — | CN | claimed |
| CN-113200929-B | Cyano quinoxaline red light thermal excitation delayed fluorescent material, synthetic method and application thereof | 黑龙江大学 | 2023-04-28 | — | — | CN | claimed |
| CN-113200929-A | Cyanoquinoxaline red-light thermal excitation delayed fluorescent material, and synthesis method and application thereof | 黑龙江大学 | 2021-08-03 | — | — | CN | claimed |
| US-10550203-B2 | Polymers functionalized with heterocyclic nitrile compounds | BRIDGESTONE CORPORATION (JP) | 2020-02-04 | — | — | US | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20180319905-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2018-11-08 | — | — | US | claimed |
| US-20170015760-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2017-01-19 | — | — | US | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| US-9469741-B2 | Polymers functionalized with heterocyclic nitrile compounds | BRIDGESTONE CORPORATION (JP) | 2016-10-18 | — | — | US | claimed |
| CN-101874044-A | Polymers functionalized with heterocyclic nitrile compounds | BRIDGESTONE CORP | 2010-10-27 | — | — | CN | claimed |
| EP-2203482-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS | Bridgestone Corporation (JP) | 2010-07-07 | — | — | EP | claimed |
| US-20100113756-A1 | LUMINESCENT METAL COMPLEXES FOR MONITORING RENAL FUNCTION | MALLINCKRODT INC. (US) | 2010-05-06 | — | — | US | claimed |
| US-7674902-B2 | Luminescent metal complexes for monitoring renal function | MALLINCKRODT INC. (US) | 2010-03-09 | — | — | US | claimed |
| WO-2009051702-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2009-04-23 | — | — | WO | claimed |
| WO-2009051700-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS | BRIDGESTONE CORPORATION (US) | 2009-04-23 | — | — | WO | claimed |
| US-20090099325-A1 | POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC NITRILE COMPOUNDS | BRIDGESTONE CORPORATION | 2009-04-16 | — | — | US | claimed |
| WO-2002094796-A2 | BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES | AXXIMA PHARMACEUTICALS AG (DE) | 2002-11-28 | — | — | WO | claimed |
| WO-1999009845-A1 | IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-03-04 | — | — | WO | claimed |
| US-4925901-A | STORAGE STAABILITY, ONIUM ION CATALYST | THE DOW CHEMICAL COMPANY (US) | 1990-05-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113756-A1 | LUMINESCENT METAL COMPLEXES FOR MONITORING RENAL FUNCTION | REN, GLS, ATP6V1B1 | MAPT 4803/4885MEN1 246/4885KMT2A 3790/4885 |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | MAPT 150/4885MEN1 722/4885KMT2A 3227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.